Veterinary Vaccines Market Size, Share, Growth Analysis, By Product Type(Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines and Others), By Animal Type(Livestock, Companion Animals), By Technology(In-Vitro, In-Vivo), By Region - Industry Forecast 2024-2031

Global Veterinary Vaccine Market size was valued at around USD 8.00 billion in 2022 and is Poised to grow from USD 8.50 billion in 2023 and is expected to reach a value of USD 13.75 billion by 2031, at a CAGR of 6.2% over the forecast period (2024–2031).

The global veterinary vaccines market is highly competitive, with several key players operating in the market. Some of the major players in the market are Zoetis Inc., Elanco Animal Health Incorporated, Merck & Co., Inc., Boehringer Ingelheim GmbH and Virbac. These players are focused on developing the new and superior vaccines to cater to the evolving wishes of the marketplace. For example, Zoetis Inc. is one of the main players within the veterinary vaccines marketplace, supplying an extensive variety of vaccines for associate animals and farm animals. The enterprise has a sturdy geographic presence and a diverse product portfolio, which gives it an aggressive aspect inside the market. Zoetis Inc. Invests closely in studies and improvement to develop new vaccines and extend its product services.  'Zoetis, Inc. (US)  ', 'Merck & Co, Inc. (US)  ', 'Boehringer Ingelheim International GmbH (Germany)  ', 'Elanco Animal Health (US)  ', 'Virbac (France)  ', 'Ceva Sante Animale (France)  ', 'Phibro Animal Health Corporation (US)  ', 'Hester Biosciences Limited (India)  ', 'Neogen Corporation (US)  ', 'HIPRA (Spain)  ', 'Biogénesis Bagó (Argentina)  ', 'Tianjin Ringpu Bio-Technology Co Ltd. (China)  ', 'China Animal Husbandry Group (China)  ', 'Jinyu Bio-technology (China)  ', 'Vaxxinova International BV (Netherlands)  ', 'Endovac Animal Health (US)  ', 'Brilliant Bio Pharma (India)  ', 'Aptimmune (US)  ', 'Indian Immunologicals Ltd. (India)  ', 'Torigen Pharmaceuticals, Inc. (US)  ', 'VEROVACCiNES GmbH (Germany)  ', 'Intas Pharmaceuticals (India)  ', 'Ourofino Animal Health (Brazil)  ', 'Biovac (Israel)  ', 'Laboratoire LCV (France) '

Zoonotic diseases are infectious illnesses that may be transmitted from animals to human beings. The emergence and spread of the zoonotic diseases, together with rabies, avian influenza, and swine flu, have increased the demand for veterinary vaccines. Vaccinating animals towards these illnesses can help prevent their transmission to people, reduce the danger of disease outbreaks, and sell public fitness. Global population increase, changing nutritional possibilities, especially in growing countries, have improved the consumption of animal protein. This trend has also brought about constructing call for animals' extra emphasis and has brought about an enormous increase inside the veterinary vaccines market. 

One of the most important trends in the veterinary vaccines market is the increasing use of recombinant vaccines. These vaccines evolved the use of superior biotechnological strategies that permit unique concentrated on of precise pathogens, enhance efficacy and protection. Vaccines a rehybrids also gain from breeds which can be much less possibly to misbehave, growing their popularity among veterinarians and pet proprietors. 

North America region dominated the global veterinary vaccines market in 2023 and is predicted to keep its dominance for the duration of the forecast duration. This growth is due to the increasing adoption of animals and the developing awareness on animal health and welfare inside the region. The United States is the largest market in North America. The demand for veterinary vaccines within the United States is driven by means of the increasing occurrence of zoonotic sicknesses, the developing demand for animal protein, and the rising quantity of pet owners. In addition, the rising incidence of canine disorders, which is increasing the adoption of vaccination for the same, and the rising pet population in the U.S. are some of the key factors contributing to the expansion of the regional market.   The Asia-Pacific region within the market is expected to witness the highest growth in the market. With disposable income increasing across the region, people are more aware of preventative animal health programs. Fellow livestock owners from India, China, Japan and the rest of Asia-Pacific are interested in regular and up-to-date vaccination. Additionally, programs are being offered with governments in the region set to simplify regulatory approvals for veterinary vaccines to meet its growing demand. This will drive market growth across the region.